Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

Korábbi kezelés

• Prior toxicity with carboplatin chemotherapy
• Has previously received anti-VEGF or anti-VEGF agents like Avastin
• Difficulty lying supine and still or severe claustrophobia which cannot be managed with medication

Más betegség

• Acute intracranial hemorrhage
• Known active Hepatitis B or Hepatitis C or HIV
• Cardiac disease or unstable hemodynamics
• Severe hypertension
• History of a bleeding disorder, coagulopathy or with a history of spontaneous tumor hemorrhage
• Active drug or alcohol use disorder
• Right to left or bi-directional cardiac shunt
• Cranial or systemic infection requiring antibiotics
• Known additional malignancy that is progression or require active treatment

Egyéb

• Ferrous metallic implanted objects in the skull or brain
• Women who are pregnant or breastfeeding
• Cerebellar spinal cord or brain stem tumor
• Significant depression not adequately controlled
• Known sensitivity to gadolinium-based contrast agents
• Known sensitivity or contraindications to ultrasound contrast agent or perflutren
• Unable to undergo MRI or contraindications to MRI such as non-MRI compatible implanted devices
• Severely impaired renal function

• Must be between 18-80 years old
• Histologically confirmed glioblastoma
• Planned for Carboplatin monotherapy
• Be willing and able to provided written informed consent/asent
• Tumor progression after first line chemo radiation
• Recovered to grade 0 or 1 or pre-treatment baseline from clinically significant toxic effects of prior therapy
• Women of childbearing potential is confirmed not pregnant. Male and Female subjects utilize highly effective contraception
• Able to communicate verbally